Biopharma separator for low to medium solid content
Ensure precise separation and high yield in biopharmaceutical production with a high-performance separator that gently handles shear-sensitive products while maintaining optimum purity and efficiency.
The GEA Pharma Separator Pure is a precision-engineered solution by GEA, designed to elevate biopharmaceutical and pharmaceutical production. This separator utilizes a patented hydrohermetic inlet to gently process shear-sensitive bioproducts, ensuring cell viability in applications like monoclonal antibody production and injectable vaccines. Distinguished by its optimized bowl design, it offers high-capacity separation with configurations available for up to 10 vol% solids, accommodating a full range of capacities with four bowl sizes. The separator integrates seamlessly into your production line with automatic CIP and ASME BPE-compliant features, offering easy validation and reduced contamination risks. Its state-of-the-art IDD Drive enhances cleanroom compatibility, cutting down maintenance with fewer wear parts. This system is suitable for continuous, automated operations and supports the flexibility of the GEA flexChange concept, transitioning static lines into adaptable ones. The solid stainless steel construction ensures durability and resistance to corrosion, compliant with rigorous GMP and FDA standards.
Benefits
- Ensures product integrity with gentle handling, preserving vital cell structures in sensitive bioproducts.
- Increases yield efficiency with optimized separation for up to 10 vol% solids.
- Minimizes contamination risk through integrated automatic CIP, enhancing product safety.
- Supports rapid process validation and compliance with ASME BPE standards, simplifying regulatory adherence.
- Enhances cleanroom operations with a closed IDD Drive system, reducing maintenance needs.
- Applications
- Liquid formulations,Pharmaceuticals,Biopharmaceuticals,Enzymes,Bioprocessing
- End products
- Protein therapeutics,Fermentation broths,Enzyme blends,Monoclonal antibodies,Insulin formulations,Injectable biologics,Oral liquid medications,Cell-based therapies,Injectable vaccines
- Steps before
- Purification,Centrifugation,Feed preparation,Emulsification
- Steps after
- Sterilization,Packing,Validation,Quality Control
- Input ingredients
- Output ingredients
- Capacity
- Full range
- Two bowl designs,four bowl sizes
- Solid Content Capacity
- Low and medium solid contents
- Solid Handling Capacity
- High Sigma clarifier bowl for up to 5 vol%
- Solid Handling Capacity
- HighVol clarifier bowl for solids up to 10 % vol%
- Nozzle Separator Capacity
- For solid contents from 10 to 35 vol% and more
- Drive Type
- Integrated Direct Drive (IDD)
- Motor Cooling
- Water cooled motor
- CIP Capability
- Automatic CIP
- Bowl Design
- Optimized for maximum yield
- Product Handling
- Gentle,shear-sensitive
- Working Mechanism
- Centrifugal separation
- Integrated Steps
- CIP (Clean-In-Place),gentle product handling
- CIP Principles
- Automatic CIP
- Batch vs Continuous Operation
- Continuous
- Automation Level
- Automatic and flexible process integration
- Nozzle Separator Capability
- Handles solid contents from 10 to 35 vol%
- Skid Design
- Optimized,plug,produce
- Capacity Range
- Multiple bowl sizes and designs
- Hydrohermetic Inlet
- Gentle feeding under liquid level
- Density/particle size
- 0.5–2.5 g/cm³ / 50–1000 µm
- Bowl size
- Available in four different sizes
- Bowl design
- High Sigma and HighVol clarifier bowls
- Skid design
- Optimized for standard and customized requirements
- Discharge method
- Smooth handling with hydrohermetic inlet
- Skid Design
- Optimized for standard and custom requirements
- Flexibility
- GEA flexChange concept
- Market info
- GEA is known for its expertise in engineering innovative and sustainable equipment and solutions, focusing on sectors such as food, beverages, pharmaceuticals, and energy, with a reputation for quality, efficiency, and advanced technological applications in industrial processing.